EVANSVILLE - As it begins commercial shipments from its new Spinlace line in the US, Berry Global has updated its latest actions in the work against the spread of coronavirus, highlighting measures that include shifting capacity to supply maximum output in response to increased demand for healthcare materials.
Berry manufactures nonwoven fabrics, which are then sold to converters who produce infection prevention items such as face masks, N95 respirators, and protective apparel.
At the end of January, the company reported the prioritization of healthcare production in its Chinese facilities in response to the increased demand for coronavirus prevention. Concurrently, the company has responded to this increased demand across North America and Europe.
